N/A
N=29
Adaptation To and Satisfaction With Contact Lens Wear In Myopic Young Adults
Myopia
Bottom Line
View on ClinicalTrials.gov: NCT04857723 ↗Enrolled (actual)
29
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Subjective Quality of Vision (QoV) — 6.1; 5.3; 4.7 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- daily disposable contact lens (Device)
- Age
- Pediatric, Adult · 17+ yrs
- Sex
- All
- Sponsor
- CooperVision, Inc.
- Primary completion
- Jun 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Quality of Vision (QoV) |
6.1; 5.3; 4.7 | — |
| SECONDARY Contact Lens Impact on Quality of Life (CLIQ) |
4.1 | — |
Summary
The purpose of this study was to assess whether young adults could adapt to and achieve satisfaction with a daily disposable contact lens.
Eligibility Criteria
Inclusion Criteria
- Is between 17 and 25 years of age (inclusive) and has full legal capacity to volunteer;
- Has read and signed an information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Has a vertex corrected spherical equivalent distance refraction that ranges between - 0.75D to -6.00D in each eye;
- Has astigmatism ≤ -0.75 DC in either eye, by refraction;
- Be correctable to better than 0.20 logMAR in each eye by refraction;
- Has habitually worn spherical soft contact lenses to correct for distance vision (i.e. no multifocal or monovision) for the past 3 months;
- Is willing to wear contact lenses for at least 10 hours a day, 6 days a week while in the study;
- Demonstrates an acceptable fit with the study lenses;
- Has ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses.
Exclusion Criteria
- Is participating in any concurrent clinical or research study;
- Has a history of amblyopia;
- Has TNO Stereoacuity worse than 120" arc / or Titmus worse than 100" arc;
- Has any known active ocular disease and/or infection;
- Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
- Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
- Has known sensitivity to the diagnostic pharmaceutical (sodium fluorescein) to be used in the study;
- Is pregnant, lactating or planning a pregnancy at the time of enrolment (verbal confirmation at the screening visit);
- Is pseudophakic;
- Has undergone refractive error surgery;
- Has one of following experiences with MiSight lenses:
- Is currently wearing MiSight lenses or
- Has worn MiSight lenses for more than one week at any given time or
- Has worn MiSight lenses for any more than 30 minutes in the past 30 days;
- Has had orthokeratology treatment within the last 3 months.
Data sourced from ClinicalTrials.gov (NCT04857723). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.